David A. Glazer sold $13M of PLTR
See Remarks at Palantir Technologies Inc.. 81,000 shares at an average of $154.47, traded Sep 2, 2025, filed Sep 4, 2025.
Score components
- +15RoleOfficer
- +25Trade size$12.5M at market
- +5Share of holdings soldSold 16% of holdings
- +15Cluster8 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +10.8%, 3m +13.9%, 6m -2.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001321655-25-000120, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 2, 2025 | MOption exercise Class A Common Stock10b5-1 | +26,513 | $4.72 | $125k | 500,912 | Sep 4, 2025 |
| Sep 2, 2025 | MOption exercise Class A Common Stock10b5-1 | +11,257 | $4.72 | $53k | 512,169 | Sep 4, 2025 |
| Sep 2, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -200 | $150.85 | $30k | 511,969 | Sep 4, 2025 |
| Sep 2, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -27,500 | $152.18 | $4.2M | 484,469 | Sep 4, 2025 |
| Sep 2, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -700 | $153.22 | $107k | 483,769 | Sep 4, 2025 |
| Sep 2, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -500 | $154.32 | $77k | 483,269 | Sep 4, 2025 |
| Sep 2, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -38,500 | $155.21 | $6.0M | 444,769 | Sep 4, 2025 |
| Sep 2, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -4,631 | $156.57 | $725k | 440,138 | Sep 4, 2025 |
| Sep 2, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -8,569 | $157.37 | $1.3M | 431,569 | Sep 4, 2025 |
| Sep 2, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -400 | $158.08 | $63k | 431,169 | Sep 4, 2025 |
| Sep 2, 2025 | MOption exercise Employee Stock Option (Right to buy)derivative10b5-1 | -11,257 | $0.00 | $0 | 0 | Sep 4, 2025 |
| Sep 2, 2025 | MOption exercise Employee Stock Option (Right to buy)derivative10b5-1 | -26,513 | $0.00 | $0 | 223,487 | Sep 4, 2025 |
Related signals
Other insiders at Palantir Technologies Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| Pro nowfree Oct 21, 2026 | Palantir Technologies Inc. | Lauren Elaina Friedman Stat director | $1.0M 5,026 shares | -10% | |
| Pro nowfree Oct 21, 2026 | Palantir Technologies Inc. | Ryan D. Taylor See Remarks | $3.6M 18,000 shares | -6% | |
| 16Weak | Palantir Technologies Inc. | Lauren Elaina Friedman Stat director | $254k 1,337 shares | -3% | |
| 28Weak | Palantir Technologies Inc. | Alexander D. Moore director | $2.8M 16,000 shares | -1% | |
| 23Weak | Palantir Technologies Inc. | Lauren Elaina Friedman Stat director | $245k 1,342 shares | -2% | |
| 29Weak | Palantir Technologies Inc. | Jeffrey Buckley See Remarks | $577k 3,305 shares | -5% | |
| 20Weak | Palantir Technologies Inc. | Alexander C. Karp See Remarks | $86M 492,348 shares | -7% | |
| 35Weak | Palantir Technologies Inc. | Alexander D. Moore director | $2.8M 16,000 shares | -1% | |
| 35Weak | Palantir Technologies Inc. | Shyam Sankar See Remarks | $5.4M 35,000 shares | -5% | |
| 28Weak | Palantir Technologies Inc. | Lauren Elaina Friedman Stat director | $500k 3,032 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.